AIDS Weekly articles from September 1995

AIDS Weekly archives from September 1995

U.S. HIV epidemic increasingly African American.
September 4, 1995... The face of the U.S. HIV epidemic is becoming increasingly African American. Analysis of anonymous blood samples from people attending sexually transmitted disease (STD) clinics shows that while HIV prevalence has decreased among white men and...

New tool boosts gene therapies for AIDS.(transduction of peripheral blood lymphocytes for culture)
September 4, 1995... An Australian research team has put a powerful new tool into the hands of researchers developing gene therapies and DNA vaccines for AIDS. The new tool provides a rapid means of growing cultures of gene-transfected primary human peripheral...

"Missing" HIV gene may be key to genetic variability.
September 4, 1995... HIV's lack of a gene present in feline immunodeficiency virus (FIV) may be the key to the its extraordinary ability to generate mutations that confound the immune system and give rise to drug-resistant viral strains. Both HIV and FIV are...

AZT protective for babies of mothers with advanced AIDS.
September 4, 1995... A report from the New York City Department of Health adds to the evidence that zidovudine is protective against mother-to-child HIV transmission, even when maternal CD4 cell counts are low. In early 1994 the U.S. National Institute of Allergy...

Gene therapy provides opportunity for long-term treatment.
September 4, 1995... The long-term treatment of anemia associated with chronic renal failure, cancer, hemophilias and HIV infections could be possible with in vivo gene transfer of recombinant human erythropoietin (Epo). The availability of recombinant human Epo...

Blood and body fluid exposure underreported in healthcare settings.
September 4, 1995... The underreporting of blood and body fluid exposures (BBF) in healthcare settings is at a level that some researchers consider to be alarming. The average underreporting for five acute care hospitals in Montreal, Quebec, Canada was 47 percent,...

Sharps disposal containers use/placement should be part of program.(for training medical personnel)
September 4, 1995... An effective program of education and training for healthcare workers should include appropriate use of safety devices as well as compliance with universal precautions. Sharps disposal containers need to be included into an extensive program...

HIV cutaneous infection mimics Kaposi's sarcoma in some AIDS patients.
September 4, 1995... Doctors shouldn't be too quick to diagnose Kaposi's sarcoma (KS) in their AIDS patients who present with the purplish skin lesions typical of the rare cancer associated with HIV, according to a recent review of opportunistic skin infections among...

New KS-associated herpes virus linked with Castleman's disease.(Kaposi's sarcoma)
September 4, 1995... A French study links the new Kaposi's sarcoma-associated herpesvirus-like DNA sequence with multicentric Castleman's disease (MCD). Kaposi's sarcoma (KS) and MCD share a close association, especially in HIV infected patients. Unpublished data...

Liposomal ddI improves efficacy.(2',3'-dideoxyinosine)
September 4, 1995... The incorporation of 2',3'-dideoxyinosine (ddI) in liposomes significantly improved the pharmacokinetics of the HIV agent after intravenous injection, according to a report from Canada. Recent molecular studies using techniques such as in situ...

Assessing the effects of maternal HIV immunization.
September 4, 1995... University of California researchers report the development of a murine model for assessing the effects of maternal immunization with HIV vaccines. It has been suggested that one way to prevent mother-to-child transmission of HIV infection is...

Mucosal B-cell response intact throughout course of AIDS.
September 4, 1995... The persistence of strong intestinal anti-HIV response even in the late stages of AIDS suggests that the mucosal B-cell responses are functionally intact throughout the course of the disease, according to a Swiss study. While mucosal and...

Guidelines on preventing infections in people with HIV released.
September 4, 1995... The U.S. Centers for Disease Control and Prevention (CDC), the U.S. National Institutes of Health (NIH), and the Infectious Disease Society of America (IDSA) have released guidelines on preventing opportunistic infections in people with HIV....

Value of pneumococcal vaccine in HIV+ undetermined.
September 4, 1995... Pneumococcal vaccination was well tolerated and reasonably effective in a group of HIV infected persons entered in a Belgian study, but the cost-effectiveness of routine immunization in this population remains to be determined. "In Belgium,...

HPV types 6 and 33 detected in PCR from Kaposi's sarcoma.(human papilloma virus, polymerase chain reaction)
September 4, 1995... The long-held suspicion that Kaposi's sarcoma is caused by a sexually transmitted infectious agent other than HIV is bolstered by a Swiss study finding that human papilloma virus (HPV) types 6 and 33 were detected by polymerase chain reaction...

Neopterin levels predictive of AIDS mortality.
September 4, 1995... Increased serum neopterin levels predict mortality, but not progression to AIDS, in HIV positive persons. "An elevated serum neopterin level is associated with an advanced clinical stage (AIDS or ARC) at baseline, and it predicts mortality...

Secretory protease inhibitor may stop HIV saliva spread.
September 4, 1995... A secretory leukocyte protease inhibitor (SLPI) has antiviral activity and may be responsible for the infrequency of oral HIV-1 transmission, according to a U.S. National Institutes of Health report. There have been numerous reports of...

New developments in the therapy of AIDS and Kaposi's sarcoma (KS).(Research Report)
September 4, 1995... According to an abstract submitted by the authors to the 19th International Congress of Chemotherapy, held July 16-21, 1995, in Montreal, Quebec, Canada, "While there have been some advances in the treatment of HIV infection, better therapy is...

Relationship of HIV envelope epitope specific cytotoxic T lymphocyte activities and preimmunization virus sequences in HIV infected patients given HIV-1 MN r-gp160 vaccine.(Research Report)
September 4, 1995... According to an abstract submitted by the authors to the International Symposium on Clinical Immunology, held July 20-23, 1995, in San Francisco, California, "We investigated the immunogen specific lymphocyte proliferative responses and human...

Cytokine imbalance caused mostly by helminthic infections is a major factor in the pathogenesis of the African pattern of AIDS.(Research Report)
September 4, 1995... According to an abstract submitted by the authors to the International Symposium on Clinical Immunology, held July 20-23, 1995, in San Francisco, California, "BACKGROUND: AIDS in Africa behaves very differently from AIDS in the developed...

Pott's disease in Haiti, 1992-1994: an experience with 43 children.(Research Report)
September 4, 1995... According to an abstract submitted by the author to the Clinical Research Meeting, held May 5-8, 1995, in San Diego, California, "Mycobacterium tuberculosis is an important cause of pneumonia and disseminated bacterial infection in Haitian...

Thymic transplantation in pediatric AIDS.(Research Report)
September 4, 1995... According to an abstract submitted by the authors to the International Symposium on Clinical Immunology, held July 20-23, 1995, in San Francisco, California, "Several lines of evidence indicate significant progressive thymic involvement with...

Effectiveness of short-course treatment of HIV related tuberculosis (TB).(Research Report)
September 4, 1995... According to an abstract submitted by the authors to the Clinical Research Meeting, held May 5-8, 1995, in San Diego, California, "HIV is an important risk factor for the development of active TB. While HIV related TB appears to respond well to...

Potential benefit of repeated plasma donation in asymptomatic HIV infected individuals.(Research Report)
September 4, 1995... According to an abstract submitted by the authors to the International Symposium on Clinical Immunology, held July 20-23, 1995, in San Francisco, California, "There has been increasing interest in treating the acquired immunodeficiency syndrome...

Immune mechanisms induced by FIV vaccination: implications for HIV vaccine development.(feline immunodeficiency virus)(Research Report)
September 4, 1995... According to an abstract submitted by the authors to the International Symposium on Clinical Immunology, held July 20-23, 1995, in San Francisco, California, "Feline immunodeficiency virus (FIV) infection in cats induces a chronic and progressive...

Detection of human immunodeficiency virus type 1 proviral DNA by PCR using an electrochemiluminescence-tagged probe.(polymerase chain reaction)(reprinted from Journal of Clinical Microbiology, August 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Clinical Microbiology, "We have developed a rapid, pseudohomogeneous assay for the detection of PCR amplicons, based on the use of electrochemiluminescence generated from a...

Detection of Epstein-Barr virus DNA in anal scrapings from HIV-positive homosexual men. (reprinted from Archives of Dermatological Research, August 1995)
September 4, 1995... According to the authors' abstract of an article published in Archives of Dermatological Research, "Epstein-Barr virus (EBV) can infect epithelial cells as well as B lymphocytes. Infection of the male and female genital tracts has recently been...

Human herpesvirus-6 and the course of human immunodeficiency virus infection.(reprinted from Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, August 1, 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, "The aim of this study is to investigate the relationship between human herpesvirus type 6 (HHV-6) and...

Inhibition of the offspring anti-recombinant gp120 antibody response to a human immunodeficiency virus vaccine by maternal immunization in a murine model.(reprinted from Journal of Infections Diseases, August 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Infectious Diseases, "A murine model was developed for assessing the effects of passively transferred polyclonal maternal anti-gp120 antibodies on the subsequent...

Four years of natural history of HIV-1 infection in African women: a prospective cohort study i Kigali (Rwanda), 1988-1993.(reprinted from Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, August 1, 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, "Clinical features and mortality due to human immunodeficiency virus type-1 (HIV-1) infection in women are...

Diagnosis and screening of HIV AIDS using clinical criteria in Tanzanian adults.(reprinted from Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, August 1, 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, "The clinical utility of the World Health Organization (WHO) clinical case definition (CCD) of acquired immune...

Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus infected patients.(reprinted from Journal of Infectious Diseases, August 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Infectious Diseases, "Antibodies of the IgM class and IgG2 and IgA2 subclasses are prominent in responses to pneumococcal polysaccharides (PPS) but may be decreased in human...

Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease.(immunoglobulin G)(reprinted from Journal of Infectious Diseases, August 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Infectious Diseases, "To evaluate the immunogenicity and safety of a 23-valent pneumococcal vaccine in human immunodeficiency virus (HIV)-seropositive patients, 80 men and...

Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine.(reprinted from Journal of Infectious Diseases, August 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Infectious Diseases, "To evaluate the association between acyclovir use and survival in patients with advanced human immunodeficiency virus infection, observational data...

Susceptibility of HIV to inactivation by disinfectants and ultraviolet light.(reprinted from Journal of Hospital Infection, July 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Hospital Infection, "Assays were developed to assess a variety of conditions and presentations of infectious HIV to potential inactivating sources. A range of commercially...

Inactivation of human immunodeficiency virus type 1 by the amine oxidase-peroxidase system.(reprinted from Journal of Clinical Microbiology, August 1995)(Periodical Report)(Abstract)
September 4, 1995... According to the authors' abstract of an article published in Journal of Clinical Microbiology, "Human immunodeficiency virus type 1 (HIV-1) is rapidly inactivated by exposure to a naturally occurring antimicrobial system consisting of...

AIDS care not color blind.
September 11, 1995... The ugly secret about AIDS in America is that the epidemic is spreading most quickly in racial and ethnic populations victimized by the U.S. healthcare system. A recent study by the U.S. Centers for Disease Control and Prevention (see AIDS...

CDC says HIV+ may need to boil drinking water. (Centers for Disease Control and Prevention)
September 11, 1995... It is possible for HIV infected persons to contract cryptosporidiosis by drinking tap water, but it is not clear how significant this risk is, according to a report from the U.S. Centers for Disease Control and Prevention (CDC). CDC researcher...

Monitoring CD4+ cells vital for diagnosis and care of HIV disease.
September 11, 1995... Yet another HIV study confirms the importance of monitoring patients' CD4(+) cell counts below a level of 0.20x10(9)/L as a guide to diagnosis and medical management. Debra L. Hanson and colleagues report their findings in "Distribution of...

New technology for evaluating drug susceptibility needed.
September 11, 1995... The development of new technologies to rapidly diagnose tuberculosis and identify patterns of drug susceptibility in immunocompromised HIV infected persons is critical, according to the director of the U.S. Centers for Disease Control and...

Anti-CD8+ response seen in long-term survivors. (of HIV infection)
September 11, 1995... A significant anti-HIV CD8(+) lymphocyte response is seen in many HIV infected nonprogressors and asymptomatic long-term survivors when infected CD4(+) cells and autologous CD8(+) cells are cocultured, according to the results of a study from the...

Naked DNA vaccine moves forward in animal tests.
September 11, 1995... Monkey experiments bolster hopes that a naked DNA HIV vaccine might one day give people with HIV infection the upper hand in their battle with HIV. The vaccine is being developed by a research team led by David B. Weiner of the University of...

rPoxvirus HIV-2 promising candidate vaccine. (Recombinant Poxvirus)
September 11, 1995... Two highly attenuated poxvirus vector-based HIV-2 recombinants may be promising candidates for the development of an AIDS vaccine, according to a report from the U.S. National Institutes of Health. Immunization schemes which involve priming...

Immunization may increase HIV virus load. (influenza immunization)
September 11, 1995... HIV-1 replication can increase in temporal association with influenza vaccination, suggesting that continued immunologic stimulation may result in increased virus load. A potential mechanism of virus induction is immune activation. Activation...

Intravitreal CMV treatment results in endophthalmitis. (cytomegalovirus)
September 11, 1995... Researchers in Spain report the occurrence of post-surgical endophthalmitis in HIV positive patients given intravitreal treatment for cytomegalovirus retinitis. Cytomegalovirus (CMV) retinitis is the most frequent eye infection in AIDS...

Teens providing AIDS awareness for peers.
September 11, 1995... Kids aren't too enthused about listening to their parents when it comes to cleaning their room, never mind the important stuff like AIDS awareness and prevention. Maybe it takes someone in their own set to get the message out, talking about it...

Most doctors don't know how to care for HIV infected patients.
September 11, 1995... More than a decade into the AIDS epidemic, most physicians are still unable to provide adequate primary care to patients with HIV infection. AIDS is the leading cause of death among U.S. men aged 15 to 44 years and the fourth leading cause of...

HIV+ should routinely undergo PPD testing. (for tuberculosis)
September 11, 1995... Tuberculin skin testing should be conducted immediately following the determination of HIV positivity, according to a newly-released quality standard from Chicago's Northwestern University and the U.S. Centers for Disease Control and Prevention...

HIV found in one of five semen samples from HIV infected men.
September 11, 1995... HIV is found in more than one out of every five semen samples from HIV infected men, a statistic that makes unprotected sex with such men very risky, researchers say. A study of more than 100 semen samples from 16 HIV positive men over a...

Acyclovir with AZT does not improve survival.
September 11, 1995... Patients with advanced HIV disease taking conventional doses of both acyclovir and zidovudine did not have increased survival when compared with those taking zidovudine alone in a study from Baltimore's Johns Hopkins University. In a widely...

Cobalamins may have efficacy against HIV.
September 11, 1995... Cobalamins may be useful agents for the treatment of HIV-1 infection, according to a report from North Carolina's Duke University. Recent studies by Levere and Debnath indicate that heme and certain porphyrins can inhibit HIV-1 infection of...

Absence of HCV replication in peripheral blood mononuclear cells by PCR. (hepatitis C virus, polymerase chain reaction)(Research Report)
September 11, 1995... According to an abstract submitted by the authors to the 19th International Congress of Chemotherapy, held July 16-21, 1995, in Montreal, Quebec, Canada, "We have studied the detection and replication of the genome of hepatitis C virus (HCV) in...

Rifabutin in therapy of HIV-1 associated pulmonary tuberculosis, indication of earlier sputum conversion in a single blinded, randomized comparative pilot study in Uganda.(Research Report)
September 11, 1995... According to an abstract submitted by the authors to the 19th International Congress of Chemotherapy, held July 16-21, 1995, in Montreal, Quebec, Canada, "INTRODUCTION: Tuberculosis is the most frequently diagnosed HIV-1 associated opportunistic...

Usefulness of rifabutin in treating tuberculosis in HIV+ patients with severe immune deficit.(Research Report)
September 11, 1995... According to an abstract submitted by the authors to the 19th International Congress of Chemotherapy, held July 16-21, 1995, in Montreal, Quebec, Canada, "AIM: Has the inclusion of rifabutine rather than rifampin in anti-tuberculosis (TB)...

Primary and acquired bacterial resistances in tuberculous patients.(Research Report)
September 11, 1995... According to an abstract submitted by the authors to the 19th International Congress of Chemotherapy, held July 16-21, 1995, in Montreal, Quebec, Canada, "A high prevalence of tuberculosis in Galicia has prompted us to study the susceptibility...

Characterization of antigen specific B cells in the peripheral blood and tissues after immunization with SIV proteins and challenges with live virus.(Research Report)
September 11, 1995... According to an abstract submitted by the authors to the International Symposium on Clinical Immunology, held July 20-23, 1995, in San Francisco, California, "Vaccine strategies developed to combat the spread of AIDS should involve protection at...

Early depression of the systemic IgA antibody response to the pneumococcal vaccine in HIV infected patients. (immunoglobulin A)(Research Report)
September 11, 1995... According to an abstract submitted by the authors to the International Symposium on Clinical Immunology, held July 20-23, 1995, in San Francisco, California, "Due to the increased susceptibility of HIV infected patients to streptococcus...

Role of serum and secretory IgA antibodies in mediating antibody-dependent cellular cytotoxicity in HIV infected individuals. (immunoglobulin A)(Research Report)
September 11, 1995... According to an abstract submitted by the authors to the International Symposium on Clinical Immunology, held July 20-23, 1995, in San Francisco, California, "Although IgA anti-HIV antibodies have been demonstrated in infected individuals, the...

Therapeutic vaccines.(Research Report)
September 11, 1995... According to an abstract submitted by the authors to the 19th International Congress of Chemotherapy, held July 16-21, 1995, in Montreal, Quebec, Canada, "Therapeutic vaccines aim at restoring immune competence to the HIV infected individual....

Methyl-glyoxal-bisguanylhydrazone (MGBG) in the treatment of relapsed AIDS related non Hodgkin's lymphoma (AIDS NHL).(Research Report)
September 11, 1995... According to an abstract submitted by the authors to the 19th International Congress of Chemotherapy, held July 16-21, 1995, in Montreal, Quebec, Canada, "As antivirals and antibiotics are prolonging the survival of patients with AIDS, the...

Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV infected subjects. (reprinted from Clinical Pharmacology and Therapeutics, July 1995)(Periodical Report)(Abstract)
September 11, 1995... According to the authors' abstract of an article published in Clinical Pharmacology & Therapeutics, "Human pharmacokinetics of an antisense oligodeoxynucleotide phosphorothioate (GEM 91) developed as an anti-human immunodeficiency virus (HIV)...

Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies. (reprinted from Clinical and Diagnostic Virology, July 1995)(Periodical Report)(Abstract)
September 11, 1995... According to the authors' abstract of an article published in Clinical and Diagnostic Virology, "OBJECTIVE: To evaluate the sensitivity of commercially available HIV-2 immunoblots and to identify the HIV-2 glycoproteins on Western blots....

Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian human immunodeficiency viruses (SHIV). (reprinted from the Proceedings of the National Academy of Sciences of the United States of America, August 1, 1995)(Periodical Report)(Abstract)
September 11, 1995... According to the authors' abstract of an article published in Proceedings of the National Academy of Sciences of the United States of America, "To elucidate the functions of human immunodeficiency virus type 1 (HIV-1) genes in a nonhuman primate...

Vaccination against AIDS in primates. (reprinted from M S - Medecine Sciences, July 1995)(Periodical Report)(Abstract)
September 11, 1995... According to the authors' abstract of an article published in M S - Medecine Sciences, "Efforts to develop a safe and effective AIDS vaccine have been facilitated by the development of several animal models. For example, chimpanzees can be...

Cryopreservation of immunocompetent T cells as a strategy against AIDS. (reprinted from Clinical Immunotherapeutics, August 1995)(Periodical Report)(Abstract)
September 11, 1995... According to the authors' abstract of an article published in Clinical Immunotherapeutics, "It seems unlikely that viral eradication, or permanent containment of viral replication, would be associated with a spontaneous and full recovery of...

Human immunodeficiency virus seroprevalence in an occupational cohort in a South African community. (reprinted from the Archives of Internal Medicine, August 7, 1995)(Periodical Report)(Abstract)
September 11, 1995... According to the authors' abstract of an article published in Archives of Internal Medicine, "BACKGROUND: In the early years of the worldwide pandemic, there were no reported cases of acquired immunodeficiency syndrome in Lesotho, a small,...

Sexually transmitted diseases and human immunodeficiency virus infection among women with genital infections in Burkina Faso. (reprinted from the International Journal of STD and AIDS, July-August 1995)(Periodical Report)(Abstract)
September 11, 1995... According to the authors' abstract of an article published in International Journal of STD & AIDS, "This study reports the prevalence of sexually transmitted diseases (STDs) among gynaecological outpatients presenting at the Bobo-Dioulasso...

Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India. (reprinted from the British Medical Journal, July 29, 1995)(Periodical Report)(Abstract)
September 11, 1995... According to the authors' abstract of an article published in British Medical Journal, "OBJECTIVE: To investigate the risk factors for HIV infection in patients attending clinics for sexually transmitted diseases in India. DESIGNS: Descriptive...

The influence of employee, job/task, and organizational factors on adherence to universal precautions among nurses. (reprinted from the International Journal of Industrial Ergonomics, July 1995)(Periodical Report)(Abstract)
September 11, 1995... According to the authors' abstract of an article published in International Journal of Industrial Ergonomics, "Universal precautions (UP) refer to recommended work practices designed to help prevent occupational exposure to HIV/AIDS and other...

Dramatic response seen in patients taking ddI and hydroxyurea.(didanosine)
September 18, 1995... A dramatic increase in CD4 counts and a drop in HIV burden occurred in subjects who received combination therapy with didanosine (ddI) and hydroxyurea in a small French clinical trial. All of the 12 asymptomatic, HIV(+) trial participants had a...

Hydroxyurea increases potency of anti-HIV drugs in two different ways.
September 18, 1995... NCI researchers say they have solved the riddle of why the cancer drug hydroxyurea enhances some anti-HIV drugs more than others. Several teams of researchers have found that hydroxyurea increases the potency of antiretroviral nucleoside...

Routine AZT may not be needed when CD4 above 500.
September 18, 1995... Routine zidovudine monotherapy may not be warranted in asymptomatic HIV-infected persons with CD4 counts greater than 500 cells per cubic millimeter, according to an AIDS Clinical Trials Group study. Zidovudine use has been associated with...

MAB R447-1 may have anti-HIV properties.(monoclonal antibody)
September 18, 1995... The anti-HIV-1 monoclonal antibody r447-1 may be useful as a therapeutic or prophylactic agent against HIV, according to a report from the pharmaceutical manufacturer Merck Research Laboratories. In earlier studies Wolff et al. found that...

New animal model for testing reverse-transcriptase inhibitors.
September 18, 1995... A monkey virus engineered to carry HIV-1 reverse transcriptase (RT) provides a much-needed animal model for testing anti-HIV drugs. Current primate models for HIV infection use simian immunodeficiency virus (SIV) or a chimeric SIV/HIV strain...

Safety of blood for transfusion is seriously questioned.
September 18, 1995... Issues emerging in the wake of the blood safety scandal in India include the allegation that more than half the blood is not screened for HIV, and available funds to fight AIDS have not been used. Reporter Sanjay Kumar noted that problems...

Newsfile internet web site new free source of medical and health news.
September 18, 1995... The world's largest producer of weekly health information has launched NewsFile on the Internet's World Wide Web. The key feature is the selection of the world's most important health news for the week and providing it free at...

DNA-based immunization may have efficacy in HIV prevention.
September 18, 1995... Injection of HIV-1 gene expression plasmids can induce potent humoral and cell-mediated immune responses and suggest that DNA vaccines may have efficacy in the immunization against HIV-1. It has been suggested that an attenuated virus vaccine...

Liposomes may induce DTH response to HIV vaccine.(delayed type hypersensitivity)
September 18, 1995... Cytokine-containing liposomes may be an effective adjuvant for the induction of a delayed-type hypersensitivity response to envelope-antigen HIV subunit vaccines, according to a report from the University of Texas M.D. Anderson Cancer Center....

Monitoring molecular epidemiology critical in AIDS trials.
September 18, 1995... Monitoring the molecular epidemiology of HIV-1 in populations being considered for AIDS vaccine trials is critical, according to a report from the U.S. Centers for Disease Control and Prevention (CDC). One of the most significant considerations...

Hospital policy to prevent disease transmission is criticized. (Australia)
September 18, 1995... A hospital in Sydney, Australia, has initiated an infectious disease labeling policy which has drawn controversy. The system involves placing color-coded wristbands (labels) that correspond to particular infections on hospital patients at the...

Homosexual intolerance: no fun being gay. (Africa)
September 18, 1995... The anti-gay sentiments of President Robert Mugabe, Zimbabwe, Africa, has won applause from some who regard homosexuality as "un-African" and despair from others over the intolerance. The can of worms was opened when the government barred the...

Herpes zoster incidence projected to rise.
September 18, 1995... Complications of herpes zoster in HIV infected patients are becoming more and more common and the incidence of these complications is likely to rise as AIDS patients live longer, according to a report from Baltimore's Johns Hopkins University....

Long-term aerosolized pentamidine appears safe.
September 18, 1995... Long-term prophylactic exposure to aerosolized pentamidine had small but significant effects on glucose homeostasis and insulin secretion but did not modify pancreatic and renal function in a French cohort. "The detrimental effects induced by...

Three hundred, thirty-three million new, STD curable cases in 1995.(sexually transmitted diseases)
September 18, 1995... According to figures released August 25, 1995, at least 333 million new cases of curable sexually transmitted diseases (STDs) will occur in the world in 1995. The figures are based on a recent study carried out by the World Health...